Dr. Adam P. Siegel
Claim this profileAurora Cancer Care-Milwaukee West
Studies Colorectal Cancer
Studies Cancer
10 reported clinical trials
30 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
KRAS negative
2Cancer
Stage IV
KRAS negative
NRAS negative
Affiliated Hospitals
Clinical Trials Adam P. Siegel is currently running
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial tests whether relugolix and radiation therapy works to shrink tumors in patients with prostate cancer that has spread in a limited way to 1 to 5 other parts of the body (oligometastatic). Testosterone can cause the growth of prostate cancer cells. Relugolix lowers the amount of testosterone made by the body. This may help stop the growth of tumor cells that need testosterone to grow. Giving relugolix with radiation therapy may help lower the chance of prostate cancer growing or spreading.
Recruiting0 awards Phase 2
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting2 awards Phase 316 criteria
More about Adam P. Siegel
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Adam P. Siegel has experience with
- Leucovorin Calcium
- Fluorouracil
- Nivolumab
- Ipilimumab
- Avelumab
- Panitumumab
Breakdown of trials Adam P. Siegel has run
Colorectal Cancer
Cancer
Colon Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam P. Siegel specialize in?
Adam P. Siegel focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Adam P. Siegel currently recruiting for clinical trials?
Yes, Adam P. Siegel is currently recruiting for 3 clinical trials in Wauwatosa Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Adam P. Siegel has studied deeply?
Yes, Adam P. Siegel has studied treatments such as Leucovorin Calcium, Fluorouracil, Nivolumab.
What is the best way to schedule an appointment with Adam P. Siegel?
Apply for one of the trials that Adam P. Siegel is conducting.
What is the office address of Adam P. Siegel?
The office of Adam P. Siegel is located at: Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin 53226 United States. This is the address for their practice at the Aurora Cancer Care-Milwaukee West.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.